《內地樓市》碧桂園(02007.HK)創辦人楊國強到順德項目工地視察
碧桂園(02007.HK)公布,創辦人楊國強及總裁莫斌日前到廣東順德北滘南平路一個商住項目工地視察指導。
楊國強先後觀摩電梯井整體提升模板、外牆橫排模板、一體系斜撐底座等新型塑膠模板的研發情況,並考察模板成型品質。
碧桂園表示,楊國強多年的關注和研發積累,令集團在科技建造方面已取得顯著進展,例如旗下科建集團已正式更名為騰越建築科技集團,以智慧建造業務為核心,聚焦科技建造方式,推動建築機械人施工技術應用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.